← 홈

Antibody

168개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 168개
AntibodystaleZhiyong YuPhase 2

Inetetamab (Inetetamab)

Metastatic Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+3
임상시험 26상태 ACTIVE
AntibodystaleRegeneronPhase 2

Cemiplimab plus REGN3767 (Cemiplimab plus REGN3767)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
임상시험 23상태 RECRUITING
AntibodystaleRocheApproved

trastuzumab (Herceptin, Trastuzumab rezetecan)

HER2-positive Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Approved#항체#면역항체+3
임상시험 19상태 RECRUITING
AntibodystaleALX Oncology Inc.Phase 2

ALX148 (Evorpacept, Evorpacept (ALX148))

Breast Cancer, Metastatic · Breast Cancer, Metastatic

#BreastCancerMetastatic#Antibody#Phase2#항체#면역항체+4
임상시험 15상태 RECRUITING
AntibodystaleRochePhase 2

trastuzumab (Herceptin, Tucatinib plus trastuzumab and pertuzumab)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
효능 ORR 11.5%임상시험 15상태 RECRUITING
AntibodystaleHoffmann-La RochePhase 2

Selicrelumab (Selicrelumab)

Metastatic Breast Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#Antibody#Phase2#항체#면역항체+2
효능 ORR 37.5%임상시험 13상태 RECRUITING
AntibodystaleMerckPhase 2

pembrolizumab (Keytruda, SD-101 + Pembrolizumab)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
효능 ORR 3.2%임상시험 4상태 RECRUITING
AntibodystaleRegeneronPhase 2

VV1 + Cemiplimab (VV1 + Cemiplimab)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
임상시험 4상태 RECRUITING
AntibodystaleRochePhase 2

trastuzumab (Herceptin, Trastuzumab and Hyaluronidase-oysk)

Her 2 Positive Breast Cancer; Breast Cancer Female · Her 2 Positive Breast Cancer

#Her2PositiveBreastCancer#Antibody#Phase2#항체#면역항체+3
임상시험 3상태 RECRUITING
AntibodystaleMacroGenicsPhase 3

margetuximab (margetuximab)

Breast Cancer; Stage II Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase3#항체#면역항체+3
효능 ORR 62.5%임상시험 3상태 ACTIVE
AntibodystaleRochePhase 3

pertuzumab (Perjeta, pertuzumab [Perjeta])

Breast Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#Antibody#Phase3#항체#면역항체+3
효능 ORR 7.1%임상시험 3상태 ACTIVE
AntibodystaleRochePhase 2

trastuzumab (Herceptin, AMG 386 and Trastuzumab)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
임상시험 2상태 RECRUITING
AntibodystaleRochePhase 2

trastuzumab (Herceptin, Atezolizumab + Trastuzumab + Vinorelbine)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase2#항체#면역항체+2
임상시험 2상태 RECRUITING
AntibodystaleRochePhase 3

HLX87 + Pertuzumab (HLX87 + Pertuzumab)

HER2 + Breast Cancer · HER2

#HER2#Antibody#Phase3#항체#면역항체+3
임상시험 2상태 RECRUITING
AntibodystaleRochePhase 2

trastuzumab (Herceptin, MK-2206 with or without Trastuzumab)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
임상시험 2상태 RECRUITING
AntibodystaleMargaret Gatti-MaysPhase 2

Naxitamab (Naxitamab)

Anatomic Stage IV Breast Cancer AJCC v8; HER2-Negative Breast Carcinoma · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
임상시험 2상태 RECRUITING
AntibodystaleNeovii BiotechPhase 2

ertumaxomab (ertumaxomab)

Metastatic Breast Cancer; Advanced Breast Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#Antibody#Phase2#항체#면역항체+3
임상시험 2상태 DISCONTINUED
AntibodystaleQuantumLeap Healthcare Collabor…Phase 2

trastuzumab (Herceptin, AMG 386 with or without Trastuzumab)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 RECRUITING
AntibodystaleQuantumLeap Healthcare Collabor…Phase 2

ARX788 + Cemiplimab (ARX788 + Cemiplimab)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 RECRUITING
AntibodystaleAlison StopeckPhase 1

durvalumab (Imfinzi, Abemaciclib, durvalumab and aromatase inhibitor)

Breast Cancer Female; Locally Advanced Breast Cancer · Breast Cancer Female

#BreastCancerFemale#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 DISCONTINUED

2 / 9 페이지

← 이전다음 →